Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for treating child asthmatic suffocating pneumonia

A composition and pneumonia technology, applied in the field of medicine, can solve the problems of decreased drug sensitivity, impact on development, and small side effects

Active Publication Date: 2013-07-24
JIANGSU SUZHONG PHARM GRP CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are actually the following problems: ① Insufficient treatment, because the basic pathogen of airway inflammation is syncytial virus, and there is no specific drug for this virus in Western medicine at present; ② Regarding the use of hormones, in infants and young children In addition to the common side effects of hormones, children who use hormones repeatedly for a long time, because hormones have the effect of antagonizing growth hormone, can also cause protein negative balance and affect development; ③Long-term use of bronchodilators It is easy to cause decreased sensitivity of β2 receptors, resulting in decreased drug sensitivity
Therefore, there is still a lack of clinically effective and less side effect drugs for the treatment of children with asthmatic pneumonia.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1, raw material drug weight ratio: 3 parts of saponins, 9 parts of loquat leaves, 15 parts of hops, 15 parts of winter melon seeds, 9 parts of orchid vanilla, 9 parts of bellflower, 10 parts of red clover, 6 parts of peucedanum, 1 part of borneol share.

Embodiment 2

[0020] Example 2, raw material drug weight ratio: 1 part of saponins, 6 parts of loquat leaves, 10 parts of hops, 10 parts of wax gourd seeds, 6 parts of blue vanilla, 6 parts of bellflower, 15 parts of red clover, 9 parts of peucedanum, 3 parts of borneol share.

Embodiment 3

[0021] Example 3, raw material drug weight ratio: 2 parts of saponins, 8 parts of loquat leaves, 12 parts of hops, 12 parts of wax gourd seeds, 8 parts of blue vanilla, 8 parts of bellflower, 12 parts of red clover, 8 parts of peucedanum, 2 parts of borneol share.

[0022] The preparation steps of Examples 1 to 3 are as follows: take loquat leaves, hops, wax gourd seeds, platycodon grandiflorum, red clover, and Radix Peucedanum, add water and decoct for 20 minutes, then add orchid vanilla and decoct for 10 minutes, filter, extract the filtrate, add to the medicinal residues Continue decocting with the same amount of water as the filtrate for 20 minutes, filter, extract the filtrate, combine the filtrates, cool down to 30°C, add acacia powder and borneol, stir well, and filter to obtain the medicinal solution.

[0023] Daily dose setting: when the child’s weight is less than 10kg, 1 part of the weight ratio of raw materials is 0.2g; when the weight of the child is 10-30kg, 1 pa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal composition for treating child asthmatic suffocating pneumonia. The medicinal composition is characterized by being processed from multiple Chinese medicines in parts by weight: 1-3 parts of Chinese honey locust, 6-9 parts of loguat leaf, 10-15 parts of european hop flower, 10-15 parts of waxgourd seed, 6-9 parts of common bluebeard herb, 6-9 parts of platycodon root, 10-15 parts of red clover flower and inflorescence, 6-9 parts of whiteflower hogfennel root and 1-3 parts of borneol. As proved by clinical experiments, the medicinal composition for treating child asthmatic suffocating pneumonia has the characteristics of good curative effect and high safety, and is worthy of clinical application and popularization.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating children with asthmatic pneumonia. Background technique [0002] Asthmatic pneumonia, also known as bronchiolitis, is more common in children under 2 years old, and occurs frequently in winter and spring. It is a common lower respiratory tract infectious disease in infants and young children. The main pathogens of asthmatic pneumonia are viruses, the most common being respiratory syncytial virus RSV. After the onset, it manifests as cough, wheezing, dyspnea, and extensive wheezing in the lungs. In severe cases, cardiac insufficiency and respiratory failure occur. The basis and pathological features of its asthma attack are airway inflammation and hyperresponsiveness, mainly manifested by inflammatory cell infiltration and epithelial cell damage mainly composed of eosinophils. Eosinophils are powerful pro-inflammatory cells. Activating T lymphocy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/85A61P11/00
Inventor 刘峰
Owner JIANGSU SUZHONG PHARM GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products